References
- Dewald G W, Wyatt W A, Juneau A L, Carlson R O, Zinsmeister A R, Jalal S M, et al. Highly sensitive fluorescence in situ hybridization method to detect double BCR/ABL fusion and monitor response to therapy in chronic myeloid leukemia. Blood 1998; 91: 3357–3365
- Landstrom A P, Tefferi A. Fluorescent in situ hybridization in the diagnosis, prognosis, and treatment monitoring of chronic myeloid leukemia. Leuk Lymphoma 2006; 47: 397–402
- Sokal J E, Gomez G A. The Philadelphia chromosome and Philadelphia chromosome mosaicism in chronic granulocytic leukemia. J Clin Oncol 1986; 4: 104–111
- Whang-Peng J, Canellos G P, Carbone P P, Tjio J H. Clinical implications of cytogenetic variants in chronic myelocytic leukemia (CML). Blood 1968; 32: 755–766
- Sokal J E. Significance of Ph1-negative marrow cells in Ph1-positive chronic granulocytic leukemia. Blood 1980; 56: 1072–1076
- Cervantes F, Rozman C, Ballesta F, Mila M. Prognostic significance of cytogenetical studies in chronic granulocytic leukaemia. Scand J Haematol 1982; 28: 77–81
- Zapata-Gayon N, Arechavala-Perichard E, Pizzuto J, Cea-Cerros G A, Gonzalez-Angulo A. Incidence of the Philadelphia chromosome and other chromosomic disturbances in adults with chronic myelocytic leukemia. Arch Invest Med (Mex) 1982; 13: 33–36
- Sokal J E, Gomez G A, Baccarani M, Tura S, Clarkson B D, Cervantes F, et al. Prognostic significance of additional cytogenetic abnormalities at diagnosis of Philadelphia chromosome-positive chronic granulocytic leukemia. Blood 1988; 72: 294–298
- Farag S S, Ruppert A S, Mrozek K, Carroll A J, Pettenati M J, Le Beau M M, et al. Prognostic significance of additional cytogenetic abnormalities in newly diagnosed patients with Philadelphia chromosome-positive chronic myelogenous leukemia treated with interferon-alpha: a Cancer and Leukemia Group B study. Int J Oncol 2004; 25: 143–151
- Vardiman J W, Harris N L, Brunning R D. The World Health Organization (WHO) classification of the myeloid neoplasms. Blood 2002; 100: 2292–2302
- Sokal J E, Cox E B, Baccarani M, Tura S, Gomez G A, Robertson J E, et al. Prognostic discrimination in “good-risk” chronic granulocytic leukemia. Blood 1984; 63: 789–799
- Dewald G W, Broderick D J, Tom W W, Hagstrom J E, Pierre R V. The efficacy of direct, 24-hour culture, and mitotic synchronization methods for cytogenetic analysis of bone marrow in neoplastic hematologic disorders. Cancer Genet Cytogenet 1985; 18: 1–10
- Ferraris A M, Canepa L, Melani C, Miglino M, Broccia G, Gaetani G F. Clonal B lymphocytes lack bcr rearrangement in Ph-positive chronic myelogenous leukaemia. Br J Haematol 1989; 73: 48–50
- Raskind W H, Ferraris A M, Najfeld V, Jacobson R J, Moohr J W, Fialkow P J. Further evidence for the existence of a clonal Ph-negative stage in some cases of Ph-positive chronic myelocytic leukemia. Leukemia 1993; 7: 1163–1167
- Terre C, Eclache V, Rousselot P, Imbert M, Charrin C, Gervais C, et al. Report of 34 patients with clonal chromosomal abnormalities in Philadelphia-negative cells during imatinib treatment of Philadelphia-positive chronic myeloid leukemia. Leukemia 2004; 18: 1340–1346